J Korean Med Sci.  2009 Jun;24(3):443-447. 10.3346/jkms.2009.24.3.443.

Non-association Between Polymorphisms of the Frizzled Receptor Genes and Bone Mineral Density in Postmenopausal Korean Women

• Kim JG
• Kim H
• Jee BC
• Suh CS
• Choi YM
• Moon SY

• KMID: 1779161
• DOI: http://doi.org/10.3346/jkms.2009.24.3.443

Abstract

We investigated the association between single nucleotide polymorphisms (SNPs) in the frizzled (FZD) genes in the Wnt signal pathway and circulating osteoprotegerin (OPG), soluble receptor activator of NF-kappaB ligand (sRANKL) levels, bone turnover markers, and bone mineral density (BMD) in postmenopausal women. The SNPs in the FZD1, FZD5, FZD6, FZD7, and FZD9 genes were analyzed by direct sequencing in 371 postmenopausal Korean women. Levels of serum OPG, sRANKL, osteocalcin, C-telopeptide of type I collagen, calcium, parathyroid hormone and calcitonin, and BMD at the lumbar spine and femoral neck were measured. The SNPs in the FZD1, FZD5, FZD7, and FZD9 genes, and in exon 2 of the FZD6 gene were not observed. No significant differences in the adjusted BMD of lumbar spine and femoral neck and serum levels of OPG, sRANKL, and bone markers were noted among the single or haplotype genotypes of the L345M and E664A SNPs in the FZD6 gene and the distributions of these single or haplotype genotypes were not different according to the bone mass status. In conclusion, the polymorphisms of the FZD genes are not associated with BMD of the lumbar spine and femoral neck, bone turnover markers, or circulating OPG-sRANKL in Korean women.

Keyword

Bone Density; Frizzled Receptors; Polymorphism, Genetic; Osteoprotegerin; Biological Markers

MeSH Terms

Alleles
Asian Continental Ancestry Group/*genetics
Child
Child, Preschool
Female
Gene Frequency
Genotype
Humans
Infant
Interleukin-10/blood/*genetics
Male
Mucocutaneous Lymph Node Syndrome/diagnosis/*genetics
Polymorphism, Genetic
Promoter Regions, Genetic
Taiwan

Reference

1. Osteoporosis prevention, diagnosis, and therapy. NIH Consensus Statement. 2007. 17:1–45.

2. Jouanny P, Guillemin F, Kuntz C, Jeandel C, Pourel J. Environmental and genetic factors affecting bone mass. Similarity of bone density among members of healthy families. Arthritis Rheum. 1995. 38:61–67.

3. Liu YZ, Liu YJ, Recker RR, Deng HW. Molecular studies of identification of genes for osteoporosis: the 2002 update. J Endocrinol. 2003. 177:147–196.

4. Gong G, Haynatzki G. Association between bone mineral density and candidate genes in different ethnic populations and its implications. Calcif Tissue Int. 2003. 72:113–123.

5. Kim JG, Lim KS, Kim EK, Choi YM, Lee JY. Association of vitamin D receptor and estrogen receptor gene polymorphisms with bone mass in postmenopausal Korean women. Menopause. 2001. 8:222–228.

6. Kim JG, Roh KR, Lee JY. The relationship among serum insulin-like growth factor-I, insulin-like growth factor-I gene polymorphism and bone mineral density in postmenopausal women in Korea. Am J Obstet Gynecol. 2002. 186:345–350.

7. Kim JG, Kwon JH, Kim SH, Choi YM, Moon SY, Lee JY. Association between vitamin D receptor gene haplotypes and bone mass in postmenopausal Korean women. Am J Obstet Gynecol. 2003. 189:1234–1240.

8. Kim JG, Kim JH, Kim JY, Ku SY, Jee BC, Suh CS, Kim SH, Choi YM. Association between the osteoprotegrin (OPG), receptor activator of NF-kB (RANK), and RANK ligand (RANKL) gene polymorphisms, and circulating OPG, soluble RANKL levels, and bone mineral density in Korean postmenopausal women. Menopause. 2007. 14:913–918.

9. Westendorf JJ, Kahler RA, Schroeder TM. Wnt signaling in osteoblasts and bone diseases. Gene. 2004. 341:19–39.

10. Baron R, Rawadi G. Targeting the Wnt/β-catenin pathway to regulate bone formation in the adult skeleton. Endocrinology. 2007. 148:2635–2643.

11. Johnson ML, Kamel MA. The Wnt signaling pathway and bone metabolism. Curr Opin Rheumatol. 2007. 19:376–382.

12. Bodine PV, Komm BS. Wnt signaling and osteoblasotogenesis. Rev Endocr Metab Disord. 2006. 7:33–39.

13. Ferrari SL, Deutsch S, Antonarakis SE. Pathogenic mutations and polymorphisms in the lipoprotein receptor-related protein 5 reveal a new biological pathway for the control of bone mass. Curr Opin Lipidol. 2005. 16:207–214.

14. Balemans W, Van Hul W. The genetics of low-density lipoprotein receptor-related protein 5 in bone: a story of extremes. Endocrinology. 2007. 148:2622–2629.

15. Kim JY, Jee BC, Suh CS, Kim SH, Choi YM, Moon SY, Kim JG. Relationship between low density lipoprotein related receptor protein 5 gene polymorphism, and bone mineral density in postmenopausal Korean women. J Korean Soc Menopause. 2007. 13:21–32.

16. Hausler KD, Horwood NJ, Chuman Y, Fisher JL, Ellis J, Martin TJ, Rubin JS, Gillespie MT. Secreted frizzled-related protein-1 inhibits RANKL-dependent osteoclast formation. J Bone Miner Res. 2004. 19:1873–1881.

17. Wang FS, Ko JY, Lin CL, Wu HL, Ke HJ, Tai PJ. Knocking down dickkopf-1 alleviates estrogen deficiency induction of bone loss. A histomorphological study in ovariectomized rats. Bone. 2007. 40:485–492.

18. Kanis JA, Melton LJ 3rd, Christiansen C, Johnston CC, Khaltaev N. The diagnosis of osteoporosis. J Bone Miner Res. 1994. 9:1137–1141.

19. Tokuhara M, Hirai M, Atomi Y, Terada M, Katoh M. Molecular cloning of human frizzled-6. Biochem Biophys Res Comm. 1998. 243:622–627.

20. Kato M, Patel MS, Levasseur R, Lobov I, Chang BH, Glass DA 2nd, Hartmann C, Li L, Hwang TH, Brayton CF, Lang RA, Karsenty G, Chan L. Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor. J Cell Biol. 2002. 157:303–314.

21. Golan T, Yaniv A, Bafico A, Liu G, Gazit A. The human frizzled 6 (HFZ6) acts as a negative regulator of the canonical Wnt-b-catenin signaling cascade. J Biol Chem. 2004. 279:14879–14888.